Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1117 of 1,261
  1. US 7009050

    5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  2. US 7008940

    Dihydrobenzofuran derivatives, process for the preparing thereof and agents

    Takeda Pharmaceutical Company Limited Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  3. US 7008781

    Method of enhancing the biological activity of ligands

    REGENERON PHARMACEUTICALS, INC. Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  4. US 7008950

    Benzofurans as suppressors of neurodegeneration

    Takeda Chemical Industries Ltd. Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  5. US 7008948

    Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  6. US 7008923

    Glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Mar 7, 2006 Β· Expires Mar 2, 2026

    expired
  7. US 7005269

    ERAAP modulators regulate immune responses

    The Regents of the University of California Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  8. US 7005411

    Method for modulating nerve cell function

    The Regents of the University of California Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  9. US 7005274

    Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass

    The Regents of the University of California Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  10. US 7005512

    Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

    The Board of Regents of the University of Texas System Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  11. US 7005262

    Methods for detecting nucleic acids encoding human telomerase reverse transcriptase

    The Regents of the University of Colorado Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  12. US 7005129

    Non-toxic mutants of pathogenic gram-negative bacteria

    The Regents of the University of California Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  13. US 7005424

    Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System Β· Granted Feb 28, 2006 Β· Expires Feb 23, 2026

    expired
  14. US 7002002

    Abundant extracellular products and methods for their production and use

    The Regents of the University of California Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  15. US 7001884

    Eglin c based drugs for treatment of disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  16. US 7001600

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  17. US 7001908

    Arylpiperazines having activity at the serotonin 1A receptor

    Avera Pharmaceuticals, Inc. Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  18. US 7001609

    Mucosal originated drug delivery systems and animal applications

    Regents of the University of Minnesota Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  19. US 7001718

    Method of inhibiting pathogenicity of infectious agents

    THE ARIZONA BOARD OF REGENTS Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  20. US 7001919

    Forms of pravastatin sodium

    Teva Gyogyszergyar Reszvenytarsasag Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  21. US 7001602

    Use of botulinum toxin therapy for urinary incontinence and related disorders

    The Regents of the University of Colorado Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  22. US 7001614

    Liposome complexes for increased systemic delivery

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  23. US 7001997

    Proteins, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Feb 21, 2006 Β· Expires Feb 16, 2026

    expired
  24. US 6998413

    Treatment of neoplasms with yujungamycins

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Feb 14, 2006 Β· Expires Feb 9, 2026

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.